Coloplast remains a long-term Buy with limited short-term upside as shares near intrinsic value. The company revised its mid-term guidance to 5–7% organic growth and EBIT margins in the mid-20% range, reflecting a more cautious outlook. Despite a DKK 3.0 billion impairment impacting full-year results, adjusted EPS grew 39.1% and free cash flow increased 16.4% year-over-year. Key risks include challenges in China, European reimbursement pressures, and U.S. competitive bidding, all factored into current guidance.
Coloplast's adjusted EPS grew 39.1% year-over-year despite a DKK 3.0 billion impairment, with free cash flow up 16.4%. For readers following health-sector stocks, here is Pluang's market snapshot as of Nov 11, 2026 02:41 WIB: out of 150 US health stocks priced on Pluang, 47 rose and 103 fell. Notable movers include CRSP at USD 45.31 with 99% sell order activity, RXRX at USD 3.50 with 100% buy order activity, and CTXR at USD 0.49 with 99% buy order activity.
Auburn National Bancorporation, Inc. announced a quarterly cash dividend of $0.27 per share, payable on December 28, 2026, to shareholders recorded by December 10, 2026. The company is the parent of AuburnBank, an Alabama state-chartered bank with ab...
OpenTable's 2027 Quebec dining trends report shows a 9% increase in restaurant bookings, with 65% of Quebecers planning to dine out as much or more in 2027. Consumers prioritize value, local favorites, and meaningful experiences, often celebrating sm...
Pepeto's crypto presale is close to selling out, having raised $11.29 million with over 43,000 holders, driven by its fee-free trading platform and AI contract checks. Meanwhile, XRP's price has dropped to $1.11, down 72% from its peak, but analysts ...
YieldMax ETFs declared weekly distributions for their Group 1 ETFs, with distribution rates ranging from about 20% to 60% annually, depending on the ETF. These distributions reflect income generated primarily from options strategies and vary signific...
EssilorLuxottica disclosed its share capital and voting rights as of October 31, 2026, reporting 464,247,548 shares outstanding and 458,376,127 real voting rights excluding treasury shares. The company applies a 31% cap on voting rights per sharehold...
